This session explores the evolving role of clinical pharmacists in optimising therapy for patients with rheumatic conditions. Attendees will gain insights into the latest pharmacological advancements—including biologic and targeted synthetic DMARDs—along with strategies for therapeutic monitoring and patient counselling. Emphasising evidence-based practice and interprofessional collaboration, the presentation equips pharmacists with the knowledge and confidence to lead in the delivery of safe, effective, and personalised rheumatologic care.

• 1) Evaluate the pharmacological principles and clinical applications of advanced therapies—including biologic and targeted synthetic DMARDs—in the management of rheumatic diseases.
• 2) Apply evidence-based strategies for monitoring therapeutic response, managing adverse effects, and optimising patient outcomes in rheumatologic care.
• 3) Demonstrate enhanced confidence in providing clinical and counselling support as part of a multidisciplinary team managing complex rheumatic conditions.